Fenofibrate Capsules 200 mg Recalled for CGMP Manufacturing Deviations
Ajanta Pharma USA Inc. is recalling Fenofibrate Capsules, USP 200 mg due to Current Good Manufacturing Practice (CGMP) deviations identified during production. The recall affects 3,648 bottles distributed nationwide.
- Product
- FENOFIBRATE — FENOFIBRATE (FENOFIBRATE)
- Category
- Drug
- Distribution
- Distributed nationwide